Table 2. Statistical results of comparison.
| Disease | SUV | SUL | P value (SUV-SUL) | Lower bound of CI for non-inferiority margin | |||
|---|---|---|---|---|---|---|---|
| AUC (95% CI) | SE | AUC (95% CI) | SE | ||||
| Follicular, transformation outcome | 0.745 (0.584–0.906) | 0.082 | 0.754 (0.542–0.965) | 1.08 | 0.93 | 0.186 | |
| Follicular, high-grade outcome (incl. grade 3B) | 0.932 (0.878–0.987) | 0.028 | 0.931 (0.873–0.989) | 0.030 | 0.96 | 0.063 | |
| Chronic lymphocytic leukemia, transformation outcome | 0.918 (0.835–1.000) | 0.043 | 0.921 (0.839–1.000) | 0.041 | 0.92 | 0.046 | |
AUC, area under the curve; CI, confidence interval; incl., including; SE, standard error; SUL, standardized uptake value normalized to lean body mass; SUV, standardized uptake value normalized to total body weight.